Japan, Jan. 16 -- CORSAIR PHARMA INC has got intellectual property rights for 'TREPROSTINIL DERIVATIVE COMPOUND AND METHOD OF USING THE SAME.' Other related details are as follows:
Application Number: JP,2024-092118
Category (FI): A61K31/145,A61K31/165,A61K31/216,A61K31/341,A61K31/357,A61K31/365,A61K31/395,A61K31/40,A61K31/4152,A61K31/421,A61K31/435,A61K31/439,A61K31/5375,A61K9/70,401,A61P29/00,A61P35/00,A61P9/10,A61P9/10,101,A61P9/12,C07C235/06,C07C235/12,C07C69/708@Z,C07C69/74@Z,C07C69/96@Z,C07D307/20,C07D321/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: June 6, 2024
Publication Date: Aug. 8, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
